TOKYO (Reuters) - Japan's health ministry will investigate the Japanese unit of Novartis AG, Japanese media said, after a ministry panel said it may have violated Japanese law when it cited studies based on manipulated data to promote its blood pressure drug Diovan.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment